Isorhamnetin

Isorhamnetin is a flavonol compound found in onions, almonds, and various plants that exhibits antioxidant properties through free radical scavenging mechanisms. This methylated quercetin derivative shows preliminary activity as a xanthine oxidase inhibitor in laboratory studies.

Origin & History

Isorhamnetin is a monomethoxyflavone classified as a flavonol, specifically a 3'-O-methylated derivative of quercetin with the chemical formula C16H12O7. It occurs naturally as a minor pigment in pungent yellow or red onions and is produced endogenously via methylation of quercetin by the enzyme quercetin 3-O-methyltransferase.

Historical & Cultural Context

No historical or traditional medicinal uses of isolated isorhamnetin are documented in the available research. The compound has been identified as a minor component in foods like onions.

Health Benefits

• Antioxidant activity - preliminary evidence only from basic research
• Xanthine oxidase inhibition - preliminary evidence only from basic research
• No human clinical evidence available for specific health benefits
• No controlled trials have been conducted on isorhamnetin supplementation
• Current evidence limited to in-vitro studies only

How It Works

Isorhamnetin functions as an antioxidant by donating hydrogen atoms to neutralize reactive oxygen species and chelating transition metals like iron and copper. The compound inhibits xanthine oxidase enzyme activity, potentially reducing uric acid production and oxidative stress. Its 3'-methoxy group differentiates it from quercetin and may influence its bioavailability and cellular uptake.

Scientific Research

No human clinical trials, RCTs, or meta-analyses for isorhamnetin were found in the research dossier. All available evidence comes from basic laboratory research showing antioxidant properties and xanthine oxidase inhibition.

Clinical Summary

No human clinical trials have been conducted specifically on isorhamnetin supplementation or isolated compounds. Available research is limited to in vitro laboratory studies and animal models examining antioxidant capacity and enzyme inhibition. The evidence base consists entirely of preliminary basic research without controlled human data. No therapeutic dosages, efficacy outcomes, or safety profiles have been established in human populations.

Nutritional Profile

Isorhamnetin (3'-methoxy quercetin, C₁₆H₁₂O₇, MW 316.26) is a methylated flavonol and O-methylated derivative of quercetin. It is not a macronutrient source; it is a bioactive polyphenolic compound found in small quantities in sea buckthorn berries (~0.2-1.5 mg/g dry weight), ginkgo biloba leaves, onions, and various medicinal herbs such as Hippophae rhamnoides and Artemisia absinthium. Typical dietary intake from food sources is estimated at low milligram quantities per day. Isorhamnetin occurs naturally as glycosides (primarily isorhamnetin-3-O-glucoside and isorhamnetin-3-O-rutinoside), which are hydrolyzed in the gut to release the aglycone. Bioavailability is relatively low, similar to other flavonols (~1-5% oral bioavailability in animal models), with extensive first-pass metabolism via glucuronidation and sulfation in the liver and intestinal wall. It is also a major metabolite of quercetin via catechol-O-methyltransferase (COMT) methylation in vivo, meaning dietary quercetin partially converts to isorhamnetin. No significant vitamin or mineral content is attributable to isorhamnetin itself.

Preparation & Dosage

No clinically studied dosage ranges have been established for isorhamnetin. No standardized forms or extracts have been studied in humans. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Isorhamnetin pairs well with **quercetin** (500-1000 mg), as both share overlapping antioxidant pathways and quercetin is its direct metabolic precursor via COMT—co-administration may saturate methylation pathways, increasing circulating levels of both flavonols. **Vitamin C** (200-500 mg) acts as a redox partner that regenerates oxidized flavonol forms and enhances overall antioxidant network capacity while improving flavonoid stability in the gut. **Piperine** (5-10 mg from black pepper extract) can significantly improve bioavailability by inhibiting UDP-glucuronosyltransferase and CYP3A4-mediated phase II metabolism, reducing first-pass clearance. **Rutin** (quercetin-3-O-rutinoside, 250-500 mg) provides a slow-release quercetin/isorhamnetin precursor via gradual colonic microbial hydrolysis, extending the duration of plasma flavonol exposure. Additionally, **omega-3 fatty acids** (1-2 g EPA/DHA) may enhance absorption of lipophilic flavonols by improving micellar solubilization during intestinal uptake.

Safety & Interactions

Safety data for isorhamnetin supplementation is not available due to lack of human studies. Potential interactions with medications metabolized by cytochrome P450 enzymes are theoretically possible but unconfirmed. As a flavonol compound, it may theoretically interact with anticoagulant medications, though this has not been documented. Pregnant and breastfeeding women should avoid supplementation due to insufficient safety data.